Ledig stilling

Utgått annonse

Søknadsfristen for denne jobbmuligheten er passert

Helse Sør-øst RHF

Postdoc in breast cancer biomarkers and spatial molecular biology

Offentlig forvaltning

A 2-year postdoc position with the possibility for 1-year extension is available in the newly started project named BC-SINFONIA within the Haugen project group at the Dept. of Tumor Biology, Institute of Cancer Research at Oslo University Hospital.

In the BC-SINFONIA project we will analyze tumor tissues from breast cancer patients enrolled in two clinical trials at Oslo University Hospital investigating use of i) chemotherapy±carboplatin (the IBCT-trial) and ii) experimental letrozole±Akt-inhibitor (the NAPEER-trial). We build on experience in protein analysis from bulk tumor tissue, but here we advance into the spatial dimension by use of new emerging technologies. Our focus is prediction of response and resistance to treatment, identification of alternative treatment options, and therapy-induced immune cell changes.

The candidate will have duties with emphasis on the computational and analytical efforts in the project, but also be included in strategic planning and have the option of responsibility for one of the work-packages. Our ambition is for the candidate to develop scientific independence in this position. The project is part of a wider initiative in Haugen’s project group converging on molecular precision oncology, and the candidate will be collaborating with the other team members on this goal.

The position is within the project group of Dr. Mads Haugland Haugen (www.ous-research.no/haugen), which is part of the Gunhild Mælandsmo lab at the Dept. of Tumor Biology, Institute of Cancer Research at Oslo University Hospital. Project co-PI in the BC-SINFONIA project is Ass. Prof./Senior Consultant Oncologist Olav Engebråten, leading the involved clinical trials.

We are seeking a skilled and highly motivated candidate capable of working both independently and collaborative within our team structure. We are excited to welcome a new group member who shares our passion for cancer research and technology, and is eager to support us in proposing and resolving scientific topics that have recently become accessible through advancements in spatial molecular analysis.


  • PhD within a relevant field.
  • Experience with biostatistics, computational research, programming language (e.g. R, Python etc).
  • Knowledge in spatial analysis, oncology, biomedical research or translational medicine is an advantage.

Personlige egenskaper:

  • Curiosity-driven and ambitious
  • Ability to work targeted and structured
  • Self-driven and creative
  • Proficiency in written and spoken English.
  • Collaborative mindset and suitability for the position

    Vi tilbyr:

    • Application letter, including short summary of previous scientific work and motivation for applying the position.
    • CV (summarizing formal education and obtained degrees, positions held, scientific publications and other relevant activity).
    • Copies of educational certificates.
    • Letter(s) of recommendation (preferred).
    • 2-3 referees with names, positions, relation to candidate and contact details (e-mail and telephone number).

    We can offer

    • A welcoming atmosphere at the largest cancer research environment in Norway.
    • Two-year position, with possibilities for one-year extension.
    • Modern locations with cutting-edge technologies available.
    • Teamwork with international collaborators and possibility for a research stay abroad.
    • Access to exceptional data from ongoing and completed clinical trials.
    • Salary in accordance with the current agreement for a position as Postdoctoral Research fellow at the Oslo University Hospital.
    • Attractive pension agreement and welfare benefits


    About the workplace

    The Institute for Cancer Research (ICR), organised as a part of the Division of Cancer Medicine at Oslo University Hospital, conducts cutting-edge cancer research ranging from basic cancer biology to translational and clinical research. It is Norway's leading cancer research institute and has a strong international standing. ICR is organised into seven departments, six research departments, plus the Department of Core Facilities. ICR has 25 research groups, more than 30 project groups (>55 PIs), and approximately 390 employees.

    Oslo University Hospital is a workplace with great diversity. We believe this is absolutely crucial to solving the tasks required of us. We therefore want this diversity to be reflected among the applicants for our positions and encourage everyone to apply regardless of who you are and what background you have.